$31.49
0.22% today
NYSE, Feb 05, 04:16 pm CET
ISIN
US0718131099
Symbol
BAX

Baxter International Stock price

$31.42
+1.76 5.93% 1M
-3.22 9.30% 6M
+2.26 7.75% YTD
-7.11 18.45% 1Y
-55.29 63.76% 3Y
-59.45 65.42% 5Y
-6.65 17.46% 10Y
NYSE, Closing price Tue, Feb 04 2025
-0.22 0.70%
ISIN
US0718131099
Symbol
BAX
Sector

Key metrics

Market capitalization $16.04b
Enterprise Value $27.89b
P/E (TTM) P/E ratio 137.03
EV/FCF (TTM) EV/FCF 49.98
EV/Sales (TTM) EV/Sales 1.99
P/S ratio (TTM) P/S ratio 1.15
P/B ratio (TTM) P/B ratio 2.04
Dividend yield 3.31%
Last dividend (FY24) $1.04
Revenue growth (TTM) Revenue growth -6.44%
Revenue (TTM) Revenue $13.99b
EBIT (operating result TTM) EBIT $1.30b
Free Cash Flow (TTM) Free Cash Flow $558.00m
Cash position $1.42b
EPS (TTM) EPS $0.23
P/E forward 291.83
P/S forward 1.52
EV/Sales forward 2.64
Short interest 4.30%
Show more

Is Baxter International a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Baxter International Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Baxter International forecast:

3x Buy
18%
12x Hold
71%
2x Sell
12%

Analyst Opinions

17 Analysts have issued a Baxter International forecast:

Buy
18%
Hold
71%
Sell
12%

Financial data from Baxter International

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
13,988 13,988
6% 6%
100%
- Direct Costs 8,815 8,815
8% 8%
63%
5,173 5,173
4% 4%
37%
- Selling and Administrative Expenses 2,166 2,166
3% 3%
15%
- Research and Development Expense 630 630
2% 2%
5%
2,377 2,377
11% 11%
17%
- Depreciation and Amortization 1,076 1,076
15% 15%
8%
EBIT (Operating Income) EBIT 1,301 1,301
7% 7%
9%
Net Profit 116 116
139% 139%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Baxter International directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Baxter International Stock News

Negative
Market Watch
2 days ago
Among the S&P 500, 91% of stocks showed early declines following President Trump's announcements of tariffs against Canada, Mexico and China.
Neutral
Reuters
2 days ago
Medical products maker Baxter International said on Monday its CEO José Almeida will retire effective immediately, after nearly a decade as the company's top boss.
Neutral
Business Wire
2 days ago
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief executive officer (CEO), will retire from his executive roles with the company, effective immediately. He will serve in an advisory capacity through Oct. 31, 2025. The Baxter Board of Directors has appointed lead independent dire...
More Baxter International News

Company Profile

Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Head office United States
CEO D. Shafer
Employees 60,000
Founded 1931
Website www.baxter.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today